No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
EVFM Evofem Biosciences
- 0.009
- 0.000-3.69%
15min DelayClose Dec 20 16:00 ET
943.09KMarket Cap0.00P/E (TTM)
0.010High0.009Low841.74KVolume0.010Open0.010Pre Close7.66KTurnover0.84%Turnover Ratio0.19P/E (Static)100.33MShares0.07552wk High-0.01P/B943.06KFloat Cap0.00652wk Low--Dividend TTM100.33MShs Float23550.000Historical High--Div YieldTTM12.30%Amplitude0.006Historical Low0.009Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic Adi Platform, Advancing Toward First-in-Human Clinical Trials
10-Q: Q3 2024 Earnings Report
8-K: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024
Evofem Biosciences 3Q Loss/Shr 2c >EVFM
Express News | Evofem Biosciences Q3 Sales USD 4.496 Million
Express News | Evofem Biosciences Q3 Net Income USD -2.365 Million
Heat List
US
Overall
Symbol
Price
% Chg
No Data